Design and synthesis of simple, yet potent and selective non-ring-A pyripyropene A-based inhibitors of acyl-coenzyme A: cholesterol acyltransferase 2 (ACAT2)

Synthesis and structure–activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: Part 1

(2013) Masaki Ohtawa et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Synthesis and structure–activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: Part 2

(2013) Masaki Ohtawa et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Synthesis and structure–activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: Part 3

(2013) Masaki Ohtawa et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Stereoselective Approach to the Racemic Oxatetracyclic Core of Platensimycin

(2013) Sakuya Horii et al.   JOURNAL OF ORGANIC CHEMISTRY

Structure-Activity Relationship Study and Total Synthesis of Pyripyropene A as a Potent ACAT2-Selective Inhibitor

(2013) Masaki Ohtawa et al.   JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN

A specific cholesterol metabolic pathway is established in a subset of HCCs for tumor growth

(2013) Ming Lu et al.   Journal of Molecular Cell Biology

Pyripyropene A, an Acyl–Coenzyme A:Cholesterol Acyltransferase 2–Selective Inhibitor, Attenuates Hypercholesterolemia and Atherosclerosis in Murine Models of Hyperlipidemia

(2011) Taichi Ohshiro et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Dauben–Michno oxidative transposition of allylic cyanohydrins — Enantiomeric switch of (–)-carvone to (+)-carvone*Based on the 2010 Bader Award Lecture.

(2011) Jason R. Hudlicky et al.   CANADIAN JOURNAL OF CHEMISTRY

Isoform-specific inhibitors of ACATs: recent advances and promising developments

(2011) Taichi Ohshiro et al.   Future Medicinal Chemistry

Total synthesis of pyripyropene A

(2011) Atsuki Odani et al.   TETRAHEDRON

S1P5 is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells

(2009) Chi-Lun Chang et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY